Boehringer Ingelheim obtains two EU CVMP positive opinions for avian influenza vaccines VAXXITEK® HVT+IBD+H5 and VAXXINACT® H5

The European Medicines Agency’s (EMA’s) Committee for Veterinary Medicinal Products (CVMP) has adopted positive opinions for two Boehringer poultry vaccines against the highly pathogenic H5 avian influenza virus1. VAXXITEK® HVT+IBD+H5 is the first trivalent vaccine offering combined protection against Marek’s disease, Infectious Bursal Disease and H5 avian influenza in chickens and turkeys in one single [...]